<h2 id="Headline">
 Headline
</h2>
<h3 id="With_a_little_help_from_my____Lassa_virus">
 With a little help from my... Lassa virus
</h3>
<p>
 <a href="http://www.uniprot.org/uniprot/Q14118">
  Dystroglycan
 </a>
 provides a physical link between components of the extracellular matrix, including laminin, and the intracellular actin cytoskeleton. This link is crucial for a number of
 <a href="http://www.ncbi.nlm.nih.gov/pubmed/20657839,23217742,12797959">
  cellular processes
 </a>
 , including laminin and basement membrane assembly, sarcolemmal stability, cell survival, peripheral nerve myelination, cell migration and epithelial polarization.
</p>
<p>
 The dystroglycan protein is
 <a href="http://www.ncbi.nlm.nih.gov/pubmed/22770978">
  extensively glycosylated
 </a>
 at multiple sites, and an
 <a href="http://www.ncbi.nlm.nih.gov/pubmed/23329833,23115008">
  unusual O-linked glycan
 </a>
 is required for proper interaction with extracellular matrix ligands including laminin. Glycosyltransferases responsible for this modification were first identified using classical biochemical techniques, and mutations in the associated genes were identified in patients presenting with one of a number of
 <a href="http://www.omim.org/search?index=entry&amp;start=1&amp;limit=10&amp;search=mddg%2A&amp;sort=score+desc%2C+prefix%5Fsort+desc&amp;limit=50&amp;field=title&amp;prefix=%23">
  dystroglycanopathies
 </a>
 . These are a heterogeneous group of disorders characterized by muscular dystrophy that can be associated with brain anomalies, mental retardation, eye malformations, and other clinical symptoms. However until recently some 50% of newly diagnosed cases of dystroglycanopathy showed no significant association with variants in known glycosyltransferase genes.
</p>
<p>
 To address this issue,
 <a href="http://www.ncbi.nlm.nih.gov/pubmed/23519211">
  Jae et al., 2013
 </a>
 developed a powerful approach to dystroglycanopathy candidate gene identification that exploits another, less beneficial property of dystroglycan. The hemorrhagic
 <a href="http://viralzone.expasy.org/all%5Fby%5Fspecies/212.html">
  Lassa virus
 </a>
 binds to glycosylated dystroglycan during infection, the efficiency of which depends on the glycosylation level. By using gene-trap insertion mutagenesis the authors were able to identify genes whose inactivation conferred resistance to Lassa virus infection, which by extension may include regulators of the level of dystroglycan glycosylation. These genes included all those previously known to be associated with a dystroglycanopathy, as well as several novel candidates. Exon sequencing of a panel of patients with severe dystroglycanopathy identified variants in two of them,
 <a href="http://www.uniprot.org/uniprot/Q9H5K3">
  POMK/SGK196
 </a>
 and
 <a href="http://www.uniprot.org/uniprot/Q9Y2B1">
  TMEM5
 </a>
 , while confirming the absence of variants in known dystroglycanopathy genes. The other candidates await further characterization.
</p>
<p>
 We may be about to witness the elucidation of the underlying genetic causes of a range of dystroglycanopathies, disorders associated with defective dystroglycan modification, through the use of a deadly virus that normally targets the affected protein.
</p>
<p>
 As of this release,
 <a href="http://www.uniprot.org/uniprot/?query=keyword:KW-1215">
  all proteins
 </a>
 involved in dystroglycanopathies can be retrieved from UniProtKB/Swiss-Prot with the keyword
 <a href="http://www.uniprot.org/keywords/KW-1215">
  Dystroglycanopathy
 </a>
 .
</p>
<h2 id="UniProtKB_news">
 UniProtKB news
</h2>
<h3 id="Removal_of_the_cross_reference_to_Pathway_Interaction_DB">
 Removal of the cross-reference to Pathway_Interaction_DB
</h3>
<p>
 Cross-references to Pathway_Interaction_DB have been removed.
</p>
<h3 id="Changes_to_the__a_href___docs_humdisease__controlled_vocabulary_of_human_diseases__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/humdisease">
  controlled vocabulary of human diseases
 </a>
</h3>
<p>
 New diseases:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03786">
   Capillary malformations, congenital, 1
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03779">
   Cardiofaciocutaneous syndrome 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03780">
   Cardiofaciocutaneous syndrome 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03781">
   Cardiofaciocutaneous syndrome 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03782">
   Cataract 15, multiple types
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03783">
   Cataract 19
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03776">
   Cataract 20, multiple types
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03788">
   Cerebellar ataxia and hypogonadotropic hypogonadism
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03793">
   Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03773">
   Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03784">
   Charcot-Marie-Tooth disease 4B3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03774">
   Congenital disorder of glycosylation 1V
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03777">
   Dystonia 4, torsion, autosomal dominant
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03794">
   Epilepsy, familial focal, with variable foci
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03790">
   GAPO syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03767">
   Glaucoma 1, open angle, F
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03795">
   Hereditary motor and sensory neuropathy, Russe type
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03798">
   Hemolytic uremic syndrome atypical 7
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03768">
   Hypogonadotropic hypogonadism 17 with or without anosmia
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03769">
   Hypogonadotropic hypogonadism 18 with or without anosmia
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03770">
   Hypogonadotropic hypogonadism 19 with or without anosmia
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03771">
   Hypogonadotropic hypogonadism 20 with or without anosmia
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03772">
   Hypogonadotropic hypogonadism 21 with or without anosmia
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03775">
   Hypomyelination with brainstem and spinal cord involvement and leg spasticity
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03778">
   Leukodystrophy, hypomyelinating, 6
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03797">
   Microcephaly-capillary malformation syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03785">
   Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A13
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03792">
   Myopia 6
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03796">
   Spermatogenic failure 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03787">
   Sturge-Weber syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03791">
   Wieacker-Wolf syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-03789">
   Yunis-Varon syndrome
  </a>
 </li>
</ul>
<p>
 Modified diseases:
</p>
<ul>
 <li>
  Cardiofaciocutaneous syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01318">
   Cardiofaciocutaneous syndrome 1
  </a>
 </li>
 <li>
  Cataract, congenital, autosomal recessive 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03191">
   Cataract 18
  </a>
 </li>
 <li>
  Cataract, congenital, cerulean type, 4 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01394">
   Cataract 21, multiple types
  </a>
 </li>
 <li>
  Cataract, congenital, nuclear, autosomal recessive 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01233">
   Cataract 22
  </a>
 </li>
 <li>
  Cataract, congenital, nuclear, autosomal recessive 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01234">
   Cataract 17, multiple types
  </a>
 </li>
 <li>
  Cataract, posterior polar, 2 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02998">
   Cataract 16, multiple types
  </a>
 </li>
 <li>
  Cataract, zonular pulverulent 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02471">
   Cataract 14, multiple types
  </a>
 </li>
 <li>
  Congenital disorder of glycosylation, X-linked -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03722">
   Congenital disorder of glycosylation 2M
  </a>
 </li>
 <li>
  Dystonia 1 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00413">
   Dystonia 1, torsion, autosomal dominant
  </a>
 </li>
 <li>
  Dystonia 3 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00414">
   Dystonia 3, torsion, X-linked
  </a>
 </li>
 <li>
  Dystonia 6 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00416">
   Dystonia 6, torsion
  </a>
 </li>
</ul>
<p>
 Deleted diseases:
</p>
<ul>
 <li>
  Cataract, pulverulent, juvenile-onset, MAF-related
 </li>
 <li>
  2-aminoadipic 2-oxoadipic aciduria
 </li>
</ul>
<h3 id="Changes_to__a_href___docs_keywlist__keywords__a_">
 Changes to
 <a href="http://www.uniprot.org/docs/keywlist">
  keywords
 </a>
</h3>
<p>
 New keywords:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1221">
   Calcium-activated potassium channel impairing toxin
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1217">
   Cell adhesion impairing toxin
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1216">
   Complement system impairing toxin
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1215">
   Dystroglycanopathy
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1219">
   Ryanodine-sensitive calcium-release channel impairing toxin
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1218">
   Voltage-gated calcium channel impairing toxin
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1220">
   Voltage-gated potassium channel impairing toxin
  </a>
 </li>
</ul>
<p>
 Modified keywords:
</p>
<ul>
 <li>
  Calcium channel inhibitor -&gt;
  <a href="http://www.uniprot.org/keywords/KW-0108">
   Calcium channel impairing toxin
  </a>
 </li>
 <li>
  Dermonecrosis -&gt;
  <a href="http://www.uniprot.org/keywords/KW-1061">
   Dermonecrotic toxin
  </a>
 </li>
 <li>
  Potassium channel inhibitor -&gt;
  <a href="http://www.uniprot.org/keywords/KW-0632">
   Potassium channel impairing toxin
  </a>
 </li>
 <li>
  Sodium channel inhibitor -&gt;
  <a href="http://www.uniprot.org/keywords/KW-0738">
   Voltage-gated sodium channel impairing toxin
  </a>
 </li>
</ul>